Search Blog
Categories
October 2017
M T W T F S S
« Sep    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Tags

IIROC Trade Halt – Confederation Minerals Ltd.

Vancouver, British Columbia–(Newsfile Corp. – October 16, 2017) – The following issues have been halted by IIROC:

Company:

Confederation Minerals Ltd.

TSX-V Symbol:

CFM

Reason:

Failure to Maintain Exchange Requirements

Halt Time (ET)

12:38

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Frontier Communications Corporation and Reminds Investors with Losses Over $100,000 to Contact the Firm

By Khang & Khang LLP IRVINE, CA / ACCESSWIRE / October 16, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Frontier Communications Corporation (“Frontier” or the “Company”) (NASDAQ: FTR). Investors who purchased or otherwise acquired shares between April 1, 2016 and May 2, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the November 27, 2017 lead plaintiff motion deadline.

If you purchased Frontier shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Frontier made materially false and/or misleading statements, and/or failed to disclose: that the Company acquired a substantial number of non-paying accounts as part of its acquisition of the wireline operations of Verizon Communications, Inc.; that the Company would be required to increase its reserves, and write off amounts from accounts receivable associated with the non-paying accounts; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. On May 2, 2017, Frontier reported a first-quarter 2017 net loss of $75 million and a year-over-year first-quarter revenue decline of $53 million. On the same day, the Company held a conference call to discuss its first quarter financial results. During the call, CFO Ralph McBride stated that approximately $16 million of the sequential revenue decline was a result of cleanup of California, Texas, and Florida non-paying accounts and the automation of legacy non-pay disconnects. When this information reached the public, shares of Frontier fell in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 477956

EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Health Insurance Innovations, Inc. and Reminds Investors with Losses to Contact the Firm

By Khang & Khang LLP

IRVINE, CA / ACCESSWIRE / October 16, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Health Insurance Innovations, Inc. (“Health Insurance Innovations” or the “Company”) (NASDAQ: HIIQ). Investors who purchased or otherwise acquired shares from August 2, 2017 through September 11, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the November 10, 2017 lead plaintiff motion deadline.

If you purchased Health Insurance Innovations shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Health Insurance Innovations made false and/or misleading statements and/or failed to disclose: that the Company’s application for a third-party insurance administrators license with the Florida Office of Insurance Regulation was denied partly because of material errors and omissions; that the Florida Office of Insurance Regulation’s rejection of its application for a third-party insurance administrators license could result in its losing licenses in the other states; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information was announced, Health Insurance Innovation’s stock price fell materially, which caused investors harm according to the Complaint.

If you want to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 joon@khanglaw.com

If you purchased Health Insurance Innovations shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Health Insurance Innovations made false and/or misleading statements and/or failed to disclose: that the Company’s application for a third-party insurance administrators license with the Florida Office of Insurance Regulation was denied partly because of material errors and omissions; that the Florida Office of Insurance Regulation’s rejection of its application for a third-party insurance administrators license could result in its losing licenses in the other states; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information was announced, Health Insurance Innovation’s stock price fell materially, which caused investors harm according to the Complaint.

If you want to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 477957

EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tech Data Corporation and Encourages Investors with Losses to Contact the Firm

By Khang & Khang LLP

IRVINE, CA / ACCESSWIRE / October 16, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Tech Data Corporation (“Tech Data” or the “Company”) (NASDAQ: TECD). Investors who purchased or otherwise acquired shares between June 1, 2017 and August 31, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the November 24, 2017 lead plaintiff motion deadline.

If you purchased Tech Data shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Tech Data made false and/or misleading statements, and/or failed to disclose: that it was experiencing execution and operational issues; that these issues were impacting the Company’s financial performance and that it would not achieve its guidance; and therefore, the Company’s financial statements were materially false and misleading at all relevant times. On August 31, 2017, during a conference call to discuss results for the second fiscal quarter ended July 31, 2017, Chief Executive Officer Robert Dutkowsky disclosed that the Company was experiencing execution and operational issues that “impacted us in this quarter in a way that was much larger than we anticipated.” When this news became public, shares of Tech Data decreased in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 477958

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against SCANA Corporation and Encourages Investors with Losses to Contact the Firm

By Lundin Law PC

LOS ANGELES, CA / ACCESSWIRE / October 16, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against SCANA Corporation (“SCANA” or the “Company”) (NYSE: SCG) concerning possible violations of federal securities laws between January 19, 2016 and September 22, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the November 27, 2017 motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, SCANA made false and/or misleading statements, and/or failed to disclose, adverse information regarding the construction of its project to build nuclear reactors at the V.C. Summer Nuclear Station in South Carolina, assuring investors that costs spending was prudent and substantial progress was being made, even when cost overruns and other delays began to materialize.

On July 31, 2017, the Company announced that it would abandon construction of the nuclear project because of cost overruns and delays. On August 4, 2017, the South Carolina Attorney General announced the opening of an investigation into the Company’s abandonment of the nuclear project. On the same day, South Carolina state senators called for a special legislative session to investigate SCANA. On September 22, 2017, the South Carolina Attorney General publicly requested that the South Carolina State Law Enforcement Division launch a criminal investigation into the project. When this information reached the public, shares of SCANA dropped in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 477959

From Bad To Worse: Glyphosate, Recently Linked to Cancer, Now Possibly Linked to Anencephaly

By Immersion Health

PORTLAND, OR / ACCESSWIRE / October 16, 2017 / Glyphosate, the active ingredient in the herbicide Roundup, was identified last year by the World Health Organization’s International Agency for Research on Cancer (“IARC”) as a “probable carcinogen.” More recently the State of California followed suit, requiring products containing glyphosate to be labeled as probably carcinogenic.

Today, Dr. Stephanie Seneff, a Senior Research Scientist at MIT, and Dr. Gregory Nigh, a naturopathic physician in Portland, Oregon, have published their review of the evidence that the heavy hand of glyphosate may even be reaching into the womb. They demonstrate that anencephaly, a tragic birth defect in which the brain of the fetus fails to develop, can be linked to glyphosate’s possible interference with fetal development in multiple ways.

“When we started this research on anencephaly, we were really just curious to see if there could be a link to glyphosate that might be apparent. The further we got into our review of the literature, we were shocked to discover that there isn’t just one link, but many, and they would all likely be happening at the same time in an exposed mother,” says Dr. Seneff, lead author of the review.

Dr. Nigh added, “We are not suggesting that glyphosate has been shown to cause anencephaly. We are saying that, given the surprising weight of the evidence that we found, the Precautionary Principle is in order until a truly independent review establishes its safety.”

The Precautionary Principle states that “if an action or policy has a suspected risk of causing harm to the public, or to the environment, in the absence of scientific consensus (that the action or policy is not harmful), the burden of proof that it is not harmful falls on those taking that action.” (Wikipedia).

While uncovering the various links between glyphosate exposure and anencephaly encompassed new research territory, Dr. Seneff said their findings were “deja vu all over again.” “I have been researching and publishing on the possible health impact of glyphosate exposure for nearly five years. Until more rigorous studies are conducted, all we can say is that the plausible biological mechanisms are there, and the strong correlation is there between exposure and associated conditions.”

When asked if she thought this most recent finding would compel regulatory agencies to investigate these links more carefully, she remarked, “Given the potential scope of this issue, that is desperately needed. But I’m not holding my breath.”

Their findings are sure to be met with resistance and outright dismissal. Even with the developmental pathways impacted clearly identified, and with strong correlations established between exposure and anencephalic births, detractors can rightly point out that correlation is not causation. As Dr. Seneff put it, “While those in government and industry carry on that debate, the concerned public should have this information so people can make their own decisions
and act accordingly.”

Full text of the article can be found here:
https://sciforschenonline.org/journals/neurology/JNNB-3-140.php

Dr. Seneff’s additional research on glyphosate and other topics can be found here: http://people.csail.mit.edu/seneff/.

Dr. Nigh’s clinic can be found here: Http://immersionhealthpdx.com.

Contact:

Dr. Seneff: seneff@csail.mit.edu

SOURCE: Immersion Health

ReleaseID: 469388

Kibali on Track as it Prepares for Completion of Underground Mine

Kibali on Track as it Prepares for Completion of Underground Mine

Kinshasa, DRC (FSCwire) – The Kibali gold mine remains on track to achieve its production target of 610 000 ounces this year as its underground operations and the integration and automation of the vertical shaft enters the final commissioning and automation stage, Randgold Resources chief executive Mark Bristow said here today. The mine is anticipating a significant increase in production once the final shaft commissioning, which remains on a tight schedule, has been completed.

At a briefing for local media, Bristow said in spite of the high level of activity at the mine, there had been a significant improvement in the safety statistics, with its total injury frequency rate continuing to decrease and lost time injury frequency rate down to 0.31 per million hours worked in the September quarter.

Following the anticipated completion of the underground mine in the fourth quarter, the only major capital project still in the works would be Kibali’s third new hydropower station, currently being constructed by an all-Congolese contracting team. Bristow said the availability of self-generated hydropower and the mine’s high degree of mechanisation and automation were important factors in Kibali’s ability to sustain its profitability throughout the ups and downs of the gold price cycle.

To date, over $2 billion has been spent on acquiring and developing Kibali, of which the majority had been paid out in the form of taxes, permits, infrastructure and payments to local contractors and suppliers.

“With capital expenditure tapering off, Kibali should now be preparing to pay back the loans taken to fund its development. We are concerned, however, that its ability to do so will be impeded by the increasing amount of debt – currently standing at over $200 million – owed to the mine by the government. TVA refunds, excess taxes and royalties in violation of the country’s mining code, make up the bulk of this amount,” Bristow said.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7304T_1-2017-10-16.pdf

This information is provided by RNS

The company news service from the London Stock Exchange

To view this press release as a PDF file, click onto the following link:

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2017 Filing Services Canada Inc.

Kibali On Track as It Prepares for Completion of Underground Mine

By Randgold Resources Limited

KINSHASA, DEMOCRATIC REPUBLIC OF THE CONGO / ACCESSWIRE / October 16, 2017 / The Kibali gold mine remains on track to achieve its production target of 610 000 ounces this year as its underground operations and the integration and automation of the vertical shaft enters the final commissioning and automation stage, Randgold Resources (NASDAQ: GOLD; LSE: RRS) Chief Executive, Mark Bristow, said today. The mine is anticipating a significant increase in production once the final shaft commissioning, which remains on a tight schedule, has been completed.

At a briefing for local media, Bristow said that in spite of the high level of activity at the mine, there had been a significant improvement in the safety statistics, with its total injury frequency rate continuing to decrease and lost time injury frequency rate down to 0.31 per million hours worked in the September quarter.

Following the anticipated completion of the underground mine in the fourth quarter, the only major capital project still in the works would be Kibali’s third new hydropower station, currently being constructed by an all-Congolese contracting team. Bristow said the availability of self-generated hydropower and the mine’s high degree of mechanization and automation were important factors in Kibali’s ability to sustain its profitability throughout the ups and downs of the gold price cycle.

To date, over $2 billion has been spent on acquiring and developing Kibali, of which the majority had been paid out in the form of taxes, permits, infrastructure, and payments to local contractors and suppliers.

“With capital expenditure tapering off, Kibali should now be preparing to pay back the loans taken to fund its development. We are concerned, however, that its ability to do so will be impeded by the increasing amount of debt – currently standing at over $200 million – owed to the mine by the government. TVA refunds, excess taxes and royalties in violation of the country’s mining code, make up the bulk of this amount,” Bristow said.

RANDGOLD RESOURCES LIMITED
Incorporated in Jersey, Channel Islands
Reg. No. 62686
LSE Trading Symbol: RRS
NASDAQ Trading Symbol: GOLD

SOURCE: Randgold Resources

ReleaseID: 477953

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

By Lundin Law PC

LOS ANGELES, CA / ACCESSWIRE / October 16, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (NASDAQ: ICPT) concerning possible violations of federal securities laws between May 31, 2016 and September 20, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the November 27, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Intercept made materially false and/or misleading statements, and/or failed to disclose, that its lead product candidate, Ocaliva, entailed undisclosed safety risks, including death, to patients suffering from primary biliary cholangitis (“PBC”). As a result, the Company’s public statements were materially false and misleading at all relevant times. On September 12, 2017, Intercept issued a letter that warned physicians against overdosing patients with Ocaliva, advising them that the drug has been connected to liver injuries and death among patients suffering from PBC. On September 21, 2017, the U.S. Food & Drug Administration issued a safety announcement entitled, “FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva for rare chronic liver disease,” warning doctors after reports of multiple deaths linked to the drug. When this news was announced, shares of Intercept lowered in value materially, which caused investors harm according to the lawsuit.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 477955

Marstone Wins 2017 WealthManagement.com Industry Award for Digital Advice

By Marstone, Inc.

NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Marstone, Inc., an enterprise financial technology company focused on digital wealth management, today announced it received the 2017 WealthManagement.com Industry Award for Digital Advice at an awards ceremony on October 11, 2017, in New York City. The award highlights Marstone’s recent collaboration with Fiserv, Inc. to create the most comprehensive institutional digital advisory platform.

Now in its third year, the WealthManagement.com Industry Awards recognize firms for innovation and leadership in support of financial advisor success as selected by a panel of industry-leading judges. Marstone was the first digital advice solution to fully integrate with Pershing, a BNY Mellon Company, and offer the Powered by Marstone™ suite of digital advice solutions, including robo advice, to their clients. This full vertical integration allows institutional clients, including banks, credit unions, insurance companies, and investment firms, to offer digital and paperless account opening and money transfer, external account aggregation, a customized risk tolerance questionnaire, portfolio proposal, and portfolio management capabilities to their clients.

Marstone is taking that functionality and offering it across custodians by partnering and integrating with Fiserv. Powered by Marstone’s integrated platform offers a truly unified experience across channels like banking, investing, and lending. This partnership increases Marstone’s ability to deploy institutions across various custodians onto the Powered by Marstone digital advice platform.

“We are honored to be recognized by WealthManagement.com for this prestigious award,” said Margaret J. Hartigan, CEO and Founder of Marstone. “We are humbled by the tremendous interest in our platform by some of the leading financial institutions both domestically and internationally and are excited to have Fiserv as a partner.”

“From the start, Fiserv recognized Marstone as a winner, as well as a company with whom we would want to partner. Together, we set out to enhance and expand digital investment and advice tools to elevate the experience for all users,” said Cheryl Nash, President, Investment Services at Fiserv. “Our collaboration has successfully led to seamless, integrated digital advice technology and a flexible, scalable solution. Marstone’s ‘Digital Advice’ award from WealthManagement.com is both validating and well-deserved.”

Marstone continues to be viewed as a best of breed partner by financial firms and the flexible digital advice platform allows each institution to tell their distinct story.

About Marstone

Marstone is a financial technology company based in New York, with additional offices in Providence, Rhode Island and San Francisco, California. The company provides banks, credit unions, mutual funds, insurance, and investment companies the ability to private label (white label) the Powered by Marstone platform, complete with custom branding, messaging and, if desired, investment and financial product mix. Marstone was conceived and developed to address three major challenges: Demystify finance for the retail investor; help financial advisors deepen their engagement with households, and help institutions retain and grow assets and talent. Additional information is available on www.marstone.com, or follow us on Twitter @MarstoneInc. Inquiries can be sent to info@marstone.com.

About Fiserv

Fiserv, Inc. enables clients worldwide to create and deliver financial services experiences that are in step with the way people live and work today. For more than 30 years, Fiserv has been a trusted leader in financial services technology, helping clients achieve best-in-class results by driving quality and innovation in payments, processing services, risk and compliance, customer and channel management, and insights and optimization. Fiserv is a member of the FORTUNE® 500 and has been named among the FORTUNE Magazine World’s Most Admired Companies® for four consecutive years, ranking first in its category for innovation in 2016 and 2017. For more information, visit fiserv.com.

Marstone Inc.
info@marstone.com
212-203-7790

SOURCE: Marstone Inc.

ReleaseID: 477954